Skip to main content
Erschienen in: Supportive Care in Cancer 6/2013

01.06.2013 | Original Article

Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review

verfasst von: Johannes Bükki, Julia Scherbel, Stephanie Stiel, Carsten Klein, Norbert Meidenbauer, Christoph Ostgathe

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Early integration of palliative care into cancer disease management is beneficial for patients with advanced tumors. However, little is known about the association of palliative care interventions with symptom burden and treatment aggressiveness at the end of life (EoL).

Methods

To assess determinants of symptom burden and treatment intensity at the EoL, a retrospective chart review was conducted in university cancer clinic outpatients who died between July 2009 and June 2011. The objective was the correlation of place of death, palliative care utilization, prior EoL discussion, and social background (determinant variables) with symptom burden and treatment intensity (outcome variables).

Results

Ninety-six patients (61 men and 35 women) died; the mean age at death was 62.4 years (range 24–83). Mean duration of treatment was 17.9 months (range 1–129). Data on the last 14 days (3) of life were available for 62 (44) patients. Forty-seven patients received aggressive EoL care which was strongly associated with hospital death (p = 0.000, χ 2 test). The 15 patients having used palliative care services or dying in a palliative care unit (PCU) had fewer symptoms (p = 0.006, t test) and interventions (p = 0.000, t test) at the EoL. Having addressed EoL issues was correlated with fewer procedures during the last 3 days (p = 0.035, t test).

Conclusions

Most cancer patients receive aggressive EoL care interfering with quality of life. Despite limitations by small sample size and missing data, the results suggest that palliative care utilization is associated with reduced symptom burden and intensity of treatment at the EoL. Timely discussion of EoL issues may reduce the number of unnecessary interventions and facilitate referral to the PCU.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC et al (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860–3866PubMedCrossRef Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC et al (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860–3866PubMedCrossRef
2.
Zurück zum Zitat Bendaly EA, Groves J, Juliar B, Gramelspacher GP (2008) Financial impact of palliative care consultation in a public hospital. J Palliat Med 11:1304–1308PubMedCrossRef Bendaly EA, Groves J, Juliar B, Gramelspacher GP (2008) Financial impact of palliative care consultation in a public hospital. J Palliat Med 11:1304–1308PubMedCrossRef
3.
Zurück zum Zitat Casarett D, Pickard A, Bailey FA, Ritchie C, Furman C et al (2008) Do palliative consultations improve patient outcomes? J Am Geriatr Soc 56:593–599PubMedCrossRef Casarett D, Pickard A, Bailey FA, Ritchie C, Furman C et al (2008) Do palliative consultations improve patient outcomes? J Am Geriatr Soc 56:593–599PubMedCrossRef
4.
Zurück zum Zitat Hanson LC, Usher B, Spragens L, Bernard S (2008) Clinical and economic impact of palliative care consultation. J Pain Symptom Manag 35:340–346CrossRef Hanson LC, Usher B, Spragens L, Bernard S (2008) Clinical and economic impact of palliative care consultation. J Pain Symptom Manag 35:340–346CrossRef
5.
Zurück zum Zitat Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A et al (2008) Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 168:1783–1790PubMedCrossRef Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A et al (2008) Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 168:1783–1790PubMedCrossRef
6.
Zurück zum Zitat Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I (2008) Effectiveness of specialized palliative care: a systematic review. JAMA 299:1698–1709PubMedCrossRef Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I (2008) Effectiveness of specialized palliative care: a systematic review. JAMA 299:1698–1709PubMedCrossRef
7.
Zurück zum Zitat Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302:741–749PubMedCrossRef Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302:741–749PubMedCrossRef
8.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef
9.
Zurück zum Zitat Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD et al (2010) Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol 28:4457–4464PubMedCrossRef Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD et al (2010) Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol 28:4457–4464PubMedCrossRef
10.
Zurück zum Zitat Ho TH, Barbera L, Saskin R, Lu H, Neville BA et al (2011) Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol 29:1587–1591PubMedCrossRef Ho TH, Barbera L, Saskin R, Lu H, Neville BA et al (2011) Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol 29:1587–1591PubMedCrossRef
11.
Zurück zum Zitat Gonsalves WI, Tashi T, Krishnamurthy J, Davies T, Ortman S et al (2011) Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran’s Affairs cancer population. J Palliat Med 14:1231–1235PubMedCrossRef Gonsalves WI, Tashi T, Krishnamurthy J, Davies T, Ortman S et al (2011) Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran’s Affairs cancer population. J Palliat Med 14:1231–1235PubMedCrossRef
12.
Zurück zum Zitat Stiel S, Pollok A, Elsner F, Lindena G, Ostgathe C et al (2012) Validation of the symptom and problem checklist of the German Hospice and Palliative Care Evaluation (HOPE). J Pain Symptom Manag 43:593–605CrossRef Stiel S, Pollok A, Elsner F, Lindena G, Ostgathe C et al (2012) Validation of the symptom and problem checklist of the German Hospice and Palliative Care Evaluation (HOPE). J Pain Symptom Manag 43:593–605CrossRef
13.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef
14.
Zurück zum Zitat Hearn J, Higginson IJ (1999) Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 8:219–227PubMedCrossRef Hearn J, Higginson IJ (1999) Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 8:219–227PubMedCrossRef
15.
Zurück zum Zitat Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA et al (2012) Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 30:4387–4395PubMedCrossRef Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA et al (2012) Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 30:4387–4395PubMedCrossRef
16.
Zurück zum Zitat Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ et al (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133–1138PubMedCrossRef Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ et al (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133–1138PubMedCrossRef
17.
Zurück zum Zitat Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD et al (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315–321PubMedCrossRef Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD et al (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315–321PubMedCrossRef
18.
Zurück zum Zitat Tang ST, Wu SC, Hung YN, Chen JS, Huang EW et al (2009) Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006. J Clin Oncol 27:4613–4618PubMedCrossRef Tang ST, Wu SC, Hung YN, Chen JS, Huang EW et al (2009) Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006. J Clin Oncol 27:4613–4618PubMedCrossRef
19.
Zurück zum Zitat Gaertner J, Wolf J, Hallek M, Glossmann JP, Voltz R (2011) Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach. Support Care Cancer 19(7):1037–1043PubMedCrossRef Gaertner J, Wolf J, Hallek M, Glossmann JP, Voltz R (2011) Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach. Support Care Cancer 19(7):1037–1043PubMedCrossRef
20.
Zurück zum Zitat Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D et al (2011) Recommending early integration of palliative care—does it work? Support Care Cancer 20(3):507–513PubMedCrossRef Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D et al (2011) Recommending early integration of palliative care—does it work? Support Care Cancer 20(3):507–513PubMedCrossRef
21.
Zurück zum Zitat Kelley AS, Morrison RS, Wenger NS, Ettner SL, Sarkisian CA (2010) Determinants of treatment intensity for patients with serious illness: a new conceptual framework. J Palliat Med 13:807–813PubMedCrossRef Kelley AS, Morrison RS, Wenger NS, Ettner SL, Sarkisian CA (2010) Determinants of treatment intensity for patients with serious illness: a new conceptual framework. J Palliat Med 13:807–813PubMedCrossRef
22.
Zurück zum Zitat Nappa U, Lindqvist O, Rasmussen BH, Axelsson B (2011) Palliative chemotherapy during the last month of life. Ann Oncol 22:2375–2380PubMedCrossRef Nappa U, Lindqvist O, Rasmussen BH, Axelsson B (2011) Palliative chemotherapy during the last month of life. Ann Oncol 22:2375–2380PubMedCrossRef
23.
Zurück zum Zitat Saito AM, Landrum MB, Neville BA, Ayanian JZ, Earle CC (2011) The effect on survival of continuing chemotherapy to near death. BMC Palliat Care 10:14PubMedCrossRef Saito AM, Landrum MB, Neville BA, Ayanian JZ, Earle CC (2011) The effect on survival of continuing chemotherapy to near death. BMC Palliat Care 10:14PubMedCrossRef
24.
Zurück zum Zitat Fukui S, Fujita J, Tsujimura M, Sumikawa Y, Hayashi Y et al (2011) Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan: a nationwide survey. Ann Oncol 22:2113–2120PubMedCrossRef Fukui S, Fujita J, Tsujimura M, Sumikawa Y, Hayashi Y et al (2011) Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan: a nationwide survey. Ann Oncol 22:2113–2120PubMedCrossRef
25.
Zurück zum Zitat Smith CB, Nelson JE, Berman AR, Powell CA, Fleischman J et al (2012) Lung cancer physicians’ referral practices for palliative care consultation. Ann Oncol 23:382–387PubMedCrossRef Smith CB, Nelson JE, Berman AR, Powell CA, Fleischman J et al (2012) Lung cancer physicians’ referral practices for palliative care consultation. Ann Oncol 23:382–387PubMedCrossRef
Metadaten
Titel
Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review
verfasst von
Johannes Bükki
Julia Scherbel
Stephanie Stiel
Carsten Klein
Norbert Meidenbauer
Christoph Ostgathe
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1721-y

Weitere Artikel der Ausgabe 6/2013

Supportive Care in Cancer 6/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.